The antiphospholipid syndrome causes venous, arterial, and small-vessel thrombosis;
pregnancy loss; and preterm delivery for patients with severe pre-eclampsia or placental …

Factor V Leiden is a genetic disorder characterized by a poor anticoagulant response to
activated Protein C and an increased risk for venous thromboembolism. Deep venous …

The antiphospholipid syndrome (APS) is defined by the presence of thrombosis and/or
pregnancy morbidity in combination with the persistent presence of circulating …

Venous thromboembolism (VTE) is major health problem and is sometimes complicated by
lethal pulmonary embolism (PE). Disturbances of the coagulation and anticoagulation …

Background: Few studies have evaluated the long‐term economic consequences of deep
vein thrombosis (DVT). None of them have incorporated prospectively collected clinical data …

Laboratory evidence of antiphospholipid antibodies (APLA) in patients with a first episode of
venous thromboembolism (VTE) is often considered an indication for indefinite …

The clinical penetrance of venous thromboembolism (VTE) susceptibility genes is variable,
being lower in heterozygous carriers of factor V Leiden and prothrombin 20210A (mild …

Отказ от ответственности. Рекомендации ЕАК отражают точку зрения ЕАК и были
подготовлены после тщательного изучения научных и медицинских данных …

It is unclear whether thrombophilia causes resistance to anticoagulant therapy. Post hoc
analyses of data from RE-COVER®, RE-COVER™ II, and RE-MEDY™ were performed to …

Background China may have the largest number of Budd–Chiari syndrome (BCS) cases in
the world (at least 1914 original papers were published, and at least 20 191 BCS patients …